abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

Muc18
Back
Total number of drugs
13
Phase II and later clinical stages
0%
Involving companies
15
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
AMT-253 ADCAMT-253 ADCAntibody drug conjugate (ADC) ADCNeoplasms Skin and Musculoskeletal DiseasesMelanoma cell adhesion molecule inhibitors DNA topoisomerase I inhibitorsMultitude Therapeutics, Inc. (China)Multitude Therapeutics, Inc. (China)Multitude Therapeutics, Inc.Phase 1/2Phase 1/2United StatesExatecan 依喜替康AMT-253 ADCIgG - nd
detail  >
212pb-TCMC-OI-3212pb-TCMC-OI-3Radiolabeled antibody Therapeutic radiopharmaceuticalsNeoplasms Respiratory Diseases Other DiseasesMelanoma cell adhesion molecule inhibitorsUniversity of OsloOslo universitetssykehus HFOncoinvent ASA (Old)Oslo universitetssykehus HFUniversity of OsloOncoinvent ASA (Old)Preclinical212 Pb212pb-TCMC-OI-3
detail  >
MCAM CAR NK Cells(New York Medical College)MCAM CAR NK Cells(New York Medical College)CAR-NKNeoplasms Skin and Musculoskeletal Diseases Other DiseasesMelanoma cell adhesion molecule inhibitorsPreclinicalMCAM CAR NK Cells(New York Medical College)
detail  >
OI-3OI-3Monoclonal antibodyNeoplasmsMelanoma cell adhesion molecule inhibitorsOncoinvent ASA (Old)Oncoinvent ASA (Old)PreclinicalOI-3
detail  >
AA-98AA-98Monoclonal antibodyNeoplasmsMelanoma cell adhesion molecule inhibitors Surface antigens modulatorsChinese Academy of SciencesMicroconstants ChinaDiscoveryDiscoveryAA-98
detail  >
CN117050186CN117050186NanobodyNeoplasms Skin and Musculoskeletal DiseasesFirst Affiliated Hospital of Shantou University Medical CollegeFirst Affiliated Hospital of Shantou University Medical CollegeDiscoveryCN117050186
detail  >
CN117050187CN117050187NanobodyNeoplasms Skin and Musculoskeletal Diseases Other DiseasesFirst Affiliated Hospital of Shantou University Medical CollegeFirst Affiliated Hospital of Shantou University Medical CollegeDiscoveryCN117050187
detail  >
Anti-MUC18 monoclonal antibodyAnti-MUC18 monoclonal antibodyMonoclonal antibodyNeoplasms Skin and Musculoskeletal DiseasesMelanoma cell adhesion molecule inhibitorsAbgenix, Inc.DiscontinuedAnti-MUC18 monoclonal antibody
detail  >
CD146-ts mAb (Syndivia)CD146-ts mAb (Syndivia)Monoclonal antibodyNeoplasms Digestive System Disorders Endocrinology and Metabolic Disease Skin and Musculoskeletal DiseasesMelanoma cell adhesion molecule inhibitorsSyndivia SASSATT PACA Corse SASPreclinicalCD146-ts mAb (Syndivia)
detail  >
Hu sCD146 (Aix-Marseille Universite)Hu sCD146 (Aix-Marseille Universite)Recombinant proteinCardiovascular Diseases Other DiseasesFibronectin stimulants integrin subunit beta 4 agonists Melanoma cell adhesion molecule stimulantsUniversité d'Aix-MarseillePendingHu sCD146 (Aix-Marseille Universite)
detail  >
Total 13 data
1
2